KCAS Bio will be exhibiting at the Immunogenicity & Bioassay Summit on October 19th-22nd in Alexandria, VA. Stop by and visit us at Booth #9.
This annual summit, hosted by the Cambridge Healthtech Institute, brings together leaders in immunogenicity assessment, bioassay development, and translational science to explore emerging strategies in drug development. With focused tracks on bioassay development, immunogenicity prediction and assessment, clinical impact, and immunology for biotherapeutics, the program offers a comprehensive platform for scientific collaboration, regulatory discussion, and innovation.
Advancing Immunogenicity and Bioassay Science at KCAS Bio
KCAS Bio is a leader in immunogenicity and bioassay science, specializing in the development of regulatory-aligned strategies and assays that drive the safe and effective advancement of biotherapeutics. From predictive immunogenicity risk assessment to anti-drug antibody (ADA) assay development and interpretation, our integrated approach helps clients understand the functional and clinical relevance of their therapies. Our expertise spans a wide range of modalities, and our advanced platforms allow us to adapt our methodologies to reflect the unique biology of each modality. With a deep understanding of immune response and therapeutic function, we deliver data that supports every stage of development.
Let’s Talk About Your Projects
Visit us at Booth #9 at the summit to learn more about KCAS Bio’s comprehensive bioanalytical services. Our team of experts are ready to discuss how we can support your immunogenicity and bioassay projects, ensuring high-quality results and regulatory compliance. Reach out to schedule a meeting during the conference.
We look forward to seeing you in Alexandria, VA this October!